NCT02456532View on ClinicalTrials.gov

Safety and Efficacy of Chronic Hypnotic Use 2

PHASE4CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

August 5, 2015

Primary Completion Date

February 22, 2022

Study Completion Date

February 22, 2022

Conditions
Chronic Insomnia
Interventions
DRUG

placebo

six months of nightly placebo

DRUG

Zolpidem CR

six months of nightly zolpidem

DRUG

Eszopiclone

Trial Locations (1)

48202

HFHS Sleep Disorders Ctr, Detroit

All Listed Sponsors
lead

Henry Ford Health System

OTHER

NCT02456532 - Safety and Efficacy of Chronic Hypnotic Use 2 | Biotech Hunter | Biotech Hunter